Honz Pharmaceutical Co., Ltd. (SHE:300086)

China flag China · Delayed Price · Currency is CNY
7.40
+0.18 (2.49%)
Apr 30, 2026, 3:04 PM CST
Market Cap3.37B +44.5%
Revenue (ttm)466.12M -0.7%
Net Income-230.14M
EPS-0.51
Shares Out455.12M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume24,661,700
Average Volume39,518,650
Open7.05
Previous Close7.22
Day's Range7.05 - 7.49
52-Week Range4.48 - 15.19
Beta0.50
RSI42.64
Earnings DateApr 29, 2026

About Honz Pharmaceutical

Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, relieving cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine; and medical, disposable, and protective face masks. It markets its products through a network of agents and sales terminals. Honz Pharmaceutical Co., Ltd. was formerly known as HaiNan Honz Pharmaceu... [Read more]

Sector Healthcare
Founded 1993
Employees 659
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300086
Full Company Profile

Financial Performance

In 2025, Honz Pharmaceutical's revenue was 466.12 million, a decrease of -1.42% compared to the previous year's 472.82 million. Losses were -230.14 million, 6.44% more than in 2024.

Financial Statements